RecruitingEN originalLiver cancer

Observational Study Protocol: LIVER-R

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Given the number of anticipated durvalumab-based treatment launches in the hepatobiliary cancer space over the next 3 years, there is a need to capture contemporary real-world data across these indications. LIVER-R is a multicountry, multicenter, observational study of patients with a confirmed diagnosis of hepatobiliary cancer treated with a durvalumab-based regimen as part of routine clinical practice or early access program (EAP). The study design will include primary and secondary data collection. The primary objective of this study is to evaluate the effectiveness of durvalumab-based regimens in real-world settings as measured by real-world overall survival. Other endpoints include demographics, clinical characteristics, clinically significant events of interest, treatment patterns, concomitant medications, and other real-world clinical endpoints (such as duration of treatment, progression-free survival, time to treatment progression, time to next treatment, recurrence-free survival, and time to treatment recurrence).

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek co najmniej 18 lat
  • Potwierdzony przez lekarza rak wątroby lub dróg żółciowych
  • Rak kwalifikuje się do leczenia lekiem durwalumab w kraju danego pacjenta lub pacjent bierze udział w programie wczesnego dostępu
  • Podpisana świadoma zgoda na udział w badaniu

✗ Disqualifies

  • Uczestnictwo w innym badaniu klinicznym leczenia nowotworów wątroby od czasu rozpoznania
  • Poprzednie leczenie innymi lekami chemicznymi lub immunologicznymi na raka wątroby
  • Przeszczepienie wątroby przed rozpoczęciem badania

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
130 Years
Last updated (source)
July 17, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (159)

Research Site

Birmingham, United States

Research Site

Mobile, United States

Research Site

Phoenix, United States

Research Site

Coronado, United States

Research Site

Los Angeles, United States

Research Site

Walnut Creek, United States

Research Site

Clermont, United States

Research Site

Gainesville, United States

Research Site

Tampa, United States

Research Site

Augusta, United States

Research Site

Evergreen Park, United States

Research Site

Hinsdale, United States

Research Site

Baton Rouge, United States

Research Site

Boston, United States

Research Site

Osage Beach, United States

Research Site

White Plains, United States

Research Site

Canton, United States

Research Site

Bethlehem, United States

Research Site

Lancaster, United States

Research Site

Philadelphia, United States

Research Site

Pittsburgh, United States

Research Site

Dallas, United States

Research Site

Temple, United States

Research Site

Spokane, United States

Research Site

Garran, Australia

Research Site

Heidelberg, Australia

Research Site

Melbourne, Australia

Research Site

Murdoch, Australia

Research Site

Sankt Pölten, Austria

Research Site

Vienna, Austria

Research Site

Linz, Austria

Research Site

Brussels, Belgium

Research Site

Bonheiden, Belgium

Research Site

Edegem, Belgium

Research Site

Leuven, Belgium

Research Site

Liège, Belgium

Research Site

Stene, Belgium

Research Site

Curitiba, Brazil

Research Site

Recife - PE, Brazil

Research Site

Porto Alegre, Brazil

Research Site

Morumbi, Brazil

Research Site

São Paulo, Brazil

Research Site

São Paulo, Brazil

Research Site

Calgary, Canada

Research Site

Edmonton, Canada

Research Site

Halifax, Canada

Research Site

London, Canada

Research Site

Strasbourg, France

Research Site

Grenoble, France

Research Site

St-Malo, France

Research Site

Mulhouse, France

Research Site

Boulogne-sur-Mer, France

Research Site

Poitiers, France

Research Site

Avignon, France

Research Site

Marseille, France

Research Site

Paris, France

Research Site

Paris, France

Research Site

Heidenheim, Germany

Research Site

Konstanz, Germany

Research Site

Schorndorf, Germany

Research Site

Mannheim, Germany

Research Site

Stuttgart, Germany

Research Site

Augsburg, Germany

Research Site

Munich, Germany

Research Site

Bremenhaven, Germany

Research Site

Kassel, Germany

Research Site

Marburg, Germany

Research Site

Wiesbaden, Germany

Research Site

Göttingen, Germany

Research Site

Hanover, Germany

Research Site

Hanover, Germany

Research Site

Rostock, Germany

Research Site

Aachen, Germany

Research Site

Bochum, Germany

Research Site

Cologne, Germany

Research Site

Dortmund, Germany

Research Site

Moers, Germany

Research Site

Stolberg, Germany

Research Site

Koblenz, Germany

Research Site

Dresden, Germany

Research Site

Leipzig, Germany

Research Site

Zwickau, Germany

Research Site

Halle, Germany

Research Site

Magdeburg, Germany

Research Site

Neumünster, Germany

Research Site

Berlin, Germany

Research Site

Berlin, Germany

Research Site

Hamburg, Germany

Research Site

Hamburg, Germany

Research Site

Chaïdári, Greece

Research Site

Athens, Greece

Research Site

Athens, Greece

Research Site

Thessaloniki, Greece

Research Site

Thessaloniki, Greece

Research Site

Larissa, Greece

Research Site

Nahariya, Israel

Research Site

Ramat Gan, Israel

Research Site

Jerusalem, Israel

Research Site

Tel Aviv, Israel

Research Site

Naples, Italy

Research Site

Rome, Italy

Research Site

Rome, Italy

Research Site

Brescia, Italy

Research Site

Milan, Italy

Research Site

Milan, Italy

Research Site

Rozzano, Italy

Research Site

Turin, Italy

Research Site

Monserrato, Italy

Research Site

Pisa, Italy

Research Site

Nagoya, Japan

Research Site

Kashiwa-shi, Japan

Research Site

Kurume, Japan

Research Site

Kanazawa, Japan

Research Site

Yokohama, Japan

Research Site

Kyoto, Japan

Research Site

Sendai, Japan

Research Site

Ōsaka-sayama, Japan

Research Site

Bergen, Norway

Research Site

Oslo, Norway

Research Site

Vila Real, Portugal

Research Site

Faro, Portugal

Research Site

Lisbon, Portugal

Research Site

Lisbon, Portugal

Research Site

San Juan, Puerto Rico

Research Site

Bucharest, Romania

Research Site

Cluj-Napoca, Romania

Research Site

Craiova, Romania

Research Site

Iași, Romania

Research Site

Riyadh, Saudi Arabia

Research Site

Jeddah, Saudi Arabia

Research Site

Singapore, Singapore

Research Site

Singapore, Singapore

Research Site

Santiago de Compostela, Spain

Research Site

Zaragoza, Spain

Research Site

Santander, Spain

Research Site

Burgos, Spain

Research Site

Poniente Sur, Spain

Research Site

Ourense, Spain

Research Site

Majadahonda, Spain

Research Site

El Palmar, Spain

Research Site

Barcelona, Spain

Research Site

Madrid, Spain

Research Site

Madrid, Spain

Research Site

Madrid, Spain

Research Site

Madrid, Spain

Research Site

Oviedo, Spain

Research Site

Pamplona, Spain

Research Site

Santa Cruz de Tenerife, Spain

Research Site

Seville, Spain

Research Site

Valencia, Spain

Research Site

Lausanne, Switzerland

Research Site

Zurich, Switzerland

Research Site

Taichung, Taiwan

Research Site

Kaohsiung City, Taiwan

Research Site

Taipei, Taiwan

Research Site

Taipei, Taiwan

Research Site

Taoyuan City, Taiwan

Research Site

Mohammed Bin Zayed City, United Arab Emirates

Research Site

Deira, United Arab Emirates

Trial contact

AstraZeneca Clinical Study Information Center

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/18/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.